[1] JIN L Y, ZHAO C J, LI H N, et al. Clinical profile, prognostic factors, and outcome prediction in hospitalized patients with bloodstream infection: results from a 10-year prospective multicenter study[J]. Front Med, 2021, 8:629671.
[2] BASSETTI M, RIGHI E, ANSALDI F, et al. A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality[J]. Intensive Care Med, 2014, 40(6):839-845.
[3] ZHENG Y J, XIE T, WU L, et al. Epidemiology, species distribution, and outcome of nosocomial Candida spp. bloodstream infection in Shanghai: an 11-year retrospective analysis in a tertiary care hospital[J]. Ann Clin Microbiol Antimicrob, 2021, 20(1):34.
[4] 叶敏纳, 张晓兵. 74例真菌血症流行病学及预后因素的回顾性分析[J]. 中国真菌学杂志, 2017, 12(5):274-278. doi:  10.3969/j.issn.1673-3827.2017.05.004
[5]

PFALLER M A, DIEKEMA D J, GIBBS D L, et al. Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005[J]. J Clin Microbiol, 2008, 46(3):842-849.
[6]

AGVALD-OHMAN C, KLINGSPOR L, HJELMQVIST H, et al. Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome[J]. Scand J Infect Dis, 2008, 40(2):145-153.
[7]

CHANG M R, CORREIA F P, COSTA L C, et al. Candida bloodstream infection: data from a teaching hospital in Mato Grosso do Sul, Brazil[J]. Rev Inst Med Trop Sao Paulo, 2008, 50(5):265-268.
[8]

LIU W, TAN J W, SUN J M, et al. Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study[J]. J Antimicrob Chemother, 2014, 69(1):162-167.
[9]

XIAO M, FAN X, CHEN S C A, et al. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance[J]. J Antimicrob Chemother, 2015, 70(3):802-810. doi:  10.1093/jac/dku460
[10] 李曼娜, 林晓莹, 黄银璇, 等. 卡泊芬净的群体药代动力学-药效动力学研究进展[J]. 中国药房, 2022, 33(5):635-640. doi:  10.6039/j.issn.1001-0408.2022.05.21
[11]

LI F Y, ZHOU M G, JIAO Z, et al. Caspofungin pharmacokinetics and probability of target attainment in ICU patients in China[J]. J Glob Antimicrob Resist, 2021, 25:238-263.